NextCure (NXTC) Reports Data Showing Anti-Siglec-15 Treatmen

NextCure (NXTC) Reports Data Showing Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

NextCure (NXTC) Reports Data Showing Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

New York , United States , Hospital For Special Surgery , American , Cathleen Raggio , Timothy Mayer , Nextcure Inc , Pamerican Society For Bone , Nasdaq , Exchange Commission , Mineral Research , Transform Infrared , Solomon Langermann , Special Surgery , Sexual Dimorphism , Treatment Effect , Adult Mice , Moderate To Severe Osteogenesis ,